Central venous catheter-related thrombosis in senile male patients: New risk factors and predictors

Abstract

Central venous catheterization (CVC)-related venous thrombosis is a common but serious clinical complication, thus prevention and treatment on this problem should be extensively investigated. In this research, we aimed to investigate the incidence rate of CVC-related venous thrombosis in senile patients and give a further discussion on the related risk factors and predictors. A total of 324 hospitalized senile male patients subjected to CVC were selected. Retrospective investigation and analysis were conducted on age, underlying diseases, clinical medications, catheterization position and side, catheter retention time, and incidence of CVC-related venous thrombosis complications. Basic laboratory test results during catheterization and thrombogenesis were also collected and analyzed. Among the 324 patients, 20 cases (6.17%) of CVC-related venous thrombosis were diagnoseds. The incidence rate of CVC-related venous thrombosis in subclavian vein catheterization was significantly lower than that in femoral vein catheterization (P<0.01) and that in internal jugular vein catheterization (P<0.05). No statistically significant difference was found between femoral vein catheterization and internal jugular vein catheterization (P<0.05). Previous venous thrombosis history (P<0.01), high lactate dehydrogenase level (P<0.01), low high-density lipoprotein (HDL) level (P<0.05), and low albumin level (P<0.05) were found as risk factors or predictors of CVC-related venous thrombosis in senile male patients. Subclavian vein catheterization was the most appropriate choice among senile patients to decrease the incidence of CVC-related venous thrombosis. Previous venous thrombosis history, high lactate dehydrogenase level, low HDL level, and low albumin level were important risk factors in predicting CVC-related venous thrombosis.

Keywords

risk factors / central venous catheterization-related venous thrombosis / senile male patients

References

[1] KujurR, RaoSM, BadwaikG, et al. . Thrombosis associated with right internal jugular central venous catheters: A prospective observational study. Indian J Crit Care Med, 2012, 16(1): 17-21 PMCID: 3338233 PMID: 22557827

[2] McGeeDC, GouldMK. Preventing complications of central venous catheterization. N Engl J Med, 2003, 348(12): 1123-1133 PMID: 12646670

[3] MassicotteMP, DixD, MonagleP, et al. . Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr, 1998, 133(6): 770-776 PMID: 9842042

[4] MonagleP, AdamsM, MahoneyM, et al. . Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res, 2000, 47(6): 763-766 PMID: 10832734

[5] DebourdeauP, ChahmiDK, ZammitC, et al. . Venous thromboembolism associated with long-term use of central venous catheter in cancer patients. Pathol Biol, 2008, 56(4): 211-219 PMID: 18395994

[6] VersoM, AgnelliG. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol, 2003, 21(19): 3665-3675 PMID: 14512399

[7] MonikaJ, AnnaC, DariuszP, et al. . Incidence and risk factors for central venous catheter-related thrombosis in hematological patients. Medical Oncology, 2014, 31(1): 1-7

[8] ParkCK, PaesBA, NagelK, et al. . Neonatal central venous catheter thrombosis: diagnosis, management and outcome. Blood Coagul Fibrinolysis, 2014, 25(2): 97-106 PMID: 24477225

[9] CuriglianoG, BalduzziA, CardilloA, et al. . Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter. Support Care Cancer, 2007, 15(10): 1213-1217 PMID: 17578607

[10] HovensMMC, SnoepJD, TamsmaJT, et al. . Aspirin in the prevention and treatment of venous thromboembolism. J Thromb Haemost, 2006, 4(7): 1470-1475 PMID: 16839339

[11] BoersmaRS, JieKS, VerbonA, et al. . Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol, 2008, 19(3): 433-442 PMID: 17962211

[12] MonikaJ, AnnaC, DariuszP, et al. . Incidence and risk factors for central venous catheter-related thrombosis in hematological patients. Med Oncol, 2014, 31(1): 1-7

[13] BoersmaRS, JieKS, VerbonA, et al. . Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol, 2008, 19(3): 433-442 PMID: 17962211

[14] RoodenCJ, TesselaarME, OsantoS, et al. . Deep vein thrombosis associated with central venous catheters—a review. J Thromb Haemost, 2005, 3(11): 2409-2419 PMID: 15975139

[15] RosovskyRP, KuterDJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management. Hematol Oncol Clin North Am, 2005, 19(1): 183-202 PMID: 15639113

[16] RichtersA, van VlietM, PeerPG, et al. . Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation. Bone Marrow Transplant, 2014, 49(2): 264-269 PMID: 24185587

[17] MerrerJ, De JongheB, GolliotF, et al. . Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA, 2001, 286(6): 700-707 PMID: 11495620

[18] TimsitJF, FarkasJC, BoyerJM, et al. . Central vein catheter-related thrombosis in intensive care patients: incidence, risk factors, and relationship with catheter-related sepsis. Chest, 1998, 114(1): 207-213 PMID: 9674471

[19] GentileA, PetitL, MassonF, et al. . Subclavian central venous catheter-related thrombosis in trauma patients: incidence, risk factors and influence of polyurethane type. Crit Care, 2013, 17(3): 103

[20] MacRaeJM, AhmedA, JohnsonN, et al. . Central vein stenosis: a common problem in patients on hemodialysis. ASAIO J, 2005, 51(1): 77-81 PMID: 15745139

[21] NaroienejadM, SaediD, RezvaniA. Prevalence of central vein stenosis following catheterization in patients with end-stage renal disease. Saudi J Kidney Dis Transplant, 2010, 21(5): 975-978

[22] CortelezziA, FracchiollaNS, MaisonneuveP. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphuma, 2003, 44(9): 1495-1501

[23] BlomJW, DoggenCJ, OsantoS, et al. . Malignancies prothrombotic mutations and the risk of venous thrombosis. JAMA, 2005, 293(6): 715-722 PMID: 15701913

[24] FonsecaV, DesouzaC, AsnaniS, et al. . Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev, 2004, 25(1): 153-175 PMID: 14769830

[25] JoksM, CzyzA, PoplawskiD, et al. . Incidence and risk factors for central venous catheter-related thrombosis in hematological patients. Med Oncol, 2014, 31(1): 772 PMCID: 3884132 PMID: 24293091

[26] LechnerD, WeltermannA. Pathophysiology of chemotherapy- associated thrombosis. Hamostaseologie, 2009, 29(1): 112-120 PMID: 19151860

[27] BaskinJ L, PuiC-H, R-eissU, et al. . Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet, 2009, 374(9684): 159-169 PMCID: 2814365 PMID: 19595350

[28] ChengY, CuiT, FuP, et al. . Dyslipidemia is associated with tunneled-cuffed catheter-related central venous thrombosis in hemodialysis patients: a retrospective, multicenter study. Artif Organs, 2013, 37(8): 155-161

[29] Anthony-LizarragaW, DaliaS, ReinertSE, et al. . Venous thrombosis in patients with chronic liver disease. Blood Coagul Fibrinolysis, 2010, 21(5): 431-435 PMID: 20595823